Reperfusion therapies and poststroke seizures

Carla Bentes1, Francesco Brigo2, Johan Zelano3

  • 1Laboratory of EEG/Sleep, Neurophysiological Monitoring Unit, Department of Neuroscience and Mental Health (Neurology), Hospital de Santa Maria, CHULN, Lisbon, Portugal; Centro de Referência de Epilepsias Refratárias from EpiCare network (European Reference Network for rare and complex Epilepsies), Hospital de Santa Maria, CHULN, Lisbon, Portugal; Department of Neuroscience and Mental Health (Neurology), Hospital de Santa Maria, CHULN, Lisbon, Portugal; Department of Neuroscience and Mental Health (Neurology), Hospital de Santa Maria, CHULN, Lisbon, Portugal.

Epilepsy & Behavior : E&B
|November 16, 2019
PubMed
Summary

Reperfusion therapies for stroke may impact seizure risk, but the exact relationship remains unclear. More research is needed to understand how these treatments affect acute symptomatic and unprovoked seizures after stroke.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
513
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
763